This article is missing information about a scientific context, discovery history, notable research, current scientific uses and medical applications (if any). Please expand the article to include this information. Further details may exist on the talk page. (May 2023) |
Caprazamycins are chemical compounds isolated from Streptomyces which have some antibiotic activity.
References
- Igarashi, Masayuki; Nakagawa, Naoko; Doi, Norio; Hattori, Seiko; Naganawa, Hiroshi; Hamada, Masa (2003). "Caprazamycin B, a Novel Anti-tuberculosis Antibiotic, from Streptomyces sp". The Journal of Antibiotics. 56 (6): 580–3. doi:10.7164/antibiotics.56.580. PMID 12931868.
- Takahashi, Yoshiaki; Igarashi, Masayuki; Miyake, Toshiaki; Soutome, Hiromi; Ishikawa, Kanae; Komatsuki, Yasuhiro; Koyama, Yoshiko; Nakagawa, Naoko; Hattori, Seiko; Inoue, Kunio; Doi, Norio; Akamatsu, Yuzuru (2013). "Novel semisynthetic antibiotics from caprazamycins A–G: Caprazene derivatives and their antibacterial activity". The Journal of Antibiotics. 66 (3): 171–8. doi:10.1038/ja.2013.9. PMID 23532021.
This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |